Baker Bros. Advisors’s Prelude Therapeutics PRLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.19M | Hold |
|
|||||
|
2025
Q1 | $7.78M | Hold |
|
|||||
|
2024
Q4 | $12.9M | Hold |
|
|||||
|
2024
Q3 | $21M | Hold |
|
|||||
|
2024
Q2 | $38.6M | Hold |
|
|||||
|
2024
Q1 | $48M | Hold |
|
|||||
|
2023
Q4 | $43.2M | Hold |
|
|||||
|
2023
Q3 | $31.3M | Hold |
|
|||||
|
2023
Q2 | $45.6M | Hold |
|
|||||
|
2023
Q1 | $57.7M | Hold |
|
|||||
|
2022
Q4 | $61.1M | Hold |
|
|||||
|
2022
Q3 | $66.9M | Hold |
|
|||||
|
2022
Q2 | $52.8M | Hold |
|
|||||
|
2022
Q1 | $69.9M | Hold |
|
|||||
|
2021
Q4 | $126M | Hold |
|
|||||
|
2021
Q3 | $316M | Hold |
|
|||||
|
2021
Q2 | $290M | Hold |
|
|||||
|
2021
Q1 | $439M | Buy |
|
|||||
|
2020
Q4 | $724M | Hold |
|
|||||
|
2020
Q3 | $305M | Buy |
|